Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Patients Swallow "Camera-in-a-Pill" To Help Doctors Check for Diseases of Esophagus, GERD

29.04.2005


A new camera-in-a-pill can help doctors diagnose and evaluate diseases of the esophagus including gastroesophageal reflux disease (GERD), erosive esophagitis and Barrett’s esophagus (a pre-cancerous condition) without the use of a traditional endoscope.



"The camera is about the size of a large vitamin pill, and is a non-invasive diagnostic alternative to traditional endoscopy, the most common procedure used to examine the esophagus, " says gastroenterologist Dr. Michael Brown of Rush University Medical Center, the first center in Chicago to offer this to patients.

"In traditional endoscopy, a long, flexible tube (endoscope) is put into the mouth and advanced down the throat into the esophagus. It requires sedation and several hours of recovery.


With the camera pill, we now have a revolutionary technology that offers a quick, easy, office-based test that may help many people avoid traditional endoscopy. It may also encourage more people to see their doctor to get checked for diseases that if caught early can be treated effectively," he said

Brown says patients fast for two hours before swallowing the camera. The smooth plastic capsule is easily swallowed with a glass of water while the patient lies on his back. The patient is raised by a 30-degree angle every two minutes over a six-minute period until he is sitting upright. The capsule makes its way thought the esophagus in about three minutes. It then glides down the esophageal tract taking about 2,600 color digital pictures (14 per second), which are transmitted, to a recording device worn around the patients waist, as a belt. After 20 minutes, the physician has sufficient video images to make an evaluation. The capsule is passed naturally and painlessly from the body within 24 to 72 hours.

Studies show that camera, called PillCam ESO, is comparable in accuracy to traditional endoscopy. Also, unlike traditional endoscopy, the procedure requires no sedation, and patients can resume normal activity immediately.

Brown trains medical residents and to make sure they understand what the patients would experience, he and several other physicians each swallowed a capsule. Brown said it was easy to do, and he sees great benefits to patients. "It’s a simple, safe and less invasive alternative. There is immediate recovery since there is no sedation, and a patient could drive himself home. There is little discomfort, and it’s convenient."

According to health experts, an estimated 61 million Americans, or 44 percent of the US adult population, have heartburn at least once a month.

GERD is the third most prevalent disease in the US with the highest annual direct costs ($9.3 billion/year). Most of the 19 million GERD sufferers experience symptoms at least twice a week. Five to 15 percent of GERD patients may have Barrett’s esophagus, a condition that increases the risk of developing esophageal cancer, the fastest growing type of cancer in America.

GERD sufferers are often treated with prescription or over-the-counter antacids. However, treatments that control symptoms do not prevent the development of more serious complications. "Millions of people are chronic antacid users and have never been evaluated for esophageal disease," says Brown. "We think that the pill camera will make it easier for people at risk to get that evaluation sooner and keep esophageal disease in check."

Brown cautions the pill camera is not for everyone. People with swallowing disorders, pacemakers or with known or suspected gastrointestinal obstruction, strictures, or fistulas are not candidates. Brown says the public may be familiar with the camera pill used for the small bowel/intestine. That camera has been used since 2001 and has been used in more than 150,000 patients nationwide.

For more information or to make an appointment, please call 312-942-5861.

Mary Ann Schultz | EurekAlert!
Further information:
http://www.rush.edu

More articles from Health and Medicine:

nachricht Cholesterol-lowering drugs may fight infectious disease
22.08.2017 | Duke University

nachricht Once invincible superbug squashed by 'superteam' of antibiotics
22.08.2017 | University at Buffalo

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

Researchers devise microreactor to study formation of methane hydrate

23.08.2017 | Materials Sciences

ShAPEing the future of magnesium car parts

23.08.2017 | Automotive Engineering

New insights into the world of trypanosomes

23.08.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>